Kallyope
Founded
2015
2015
Geography
United States of America based
United States of America based
Funding
$131 M
$131 M
Kallyope is a platform biotechnology company dedicated to unlocking the therapeutic potential of the gut-brain axis. The company integrates cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology that will lead to transformational therapeutics that improve human health. The company’s founders are Charles Zuker, Ph.D., Lasker Award winner Tom Maniatis, Ph.D. and Nobel laureate Richard Axel, M.D. Headquartered at the Alexandria Center® for Life Science in New York City.
Technologies
Microbiome StartupsPosts Mentioning This Company
R&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet